Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
نویسندگان
چکیده
منابع مشابه
Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures
BACKGROUND A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbekistan in 2003. This region has particularly high levels of MDR-TB, with 13% and 40% among new and previously treated cases, respectively. METHODOLOGY This study describes the treatment process and outcomes for the first cohort of patients enrolled in the programme, between October 200...
متن کاملModelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
BACKGROUND Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. A 9-11 month regimen with seven antibiotics has shown high success rates among selected MDR-TB patients in different settings and is conditionally recommended by the World Healt...
متن کاملMultidrug-resistant tuberculosis in Uzbekistan: results
D J Ulmasova1, G Uzakova2, M N Tillyashayhov3, L Turaev4, W van Gemert5, H Hoffmann6, M Zignol5, K Kremer7, T Gombogaram8, J Gadoev8, P du Cros9, N Muslimova4, A Jalolov2, A Dadu7, P de Colombani7, O Telnov10, A Slizkiy10, B Kholikulov1, M Dara7, D Falzon ([email protected])5 1. Republican DOTS Centre, Tashkent, Uzbekistan 2. Programme Implementation Unit, The Global Fund to Fight AIDS, TB and Ma...
متن کاملThe shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?
Multidrug-resistant tuberculosis (MDR-TB) is a major public health challenge, with an estimated 480000 new cases emerging globally each year [1]. Treatment success rates using the 20-month conventional World Health Organization (WHO) regimen have been low, being about 52% in 2013 [1]. Observational studies in Bangladesh and several African countries have shown success rates of 84% using a short...
متن کاملShorter treatment duration for selected patients with multidrug-resistant tuberculosis.
Opinion and Marketing Research. ICC/ESOMAR International Code On Market and Social Research www.esomar.org/index. php/codes-guidelines.html Date last updated: December 2007. 6 Heck JE, Stücker I, Allwright S, et al. Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic. Eur Respir J 2010; 35: 969–979. 7 Winickoff JP, Gottlieb M, Mello MM. Regulation of smoking...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ERJ Open Research
سال: 2020
ISSN: 2312-0541
DOI: 10.1183/23120541.00537-2020